MICHAEL DUPRE: Open Payments
NPI 1154403491 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 17 payments from 4 companies in 2025. Trend: 2023 $1,071 · 2024 $523 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 14 | $267 |
| Karyopharm Therapeutics Inc. | 1 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $117 |
| PFIZER INC. | 1 | $108 |
Products named: Vyloy, XPOVIO, FRUZAQLA, TALZENNA.
Industry payments across OR — which companies pay providers there.
